| CQ Ranking |
|---|
| Home | Women |
| What's CQ? | Rules & Pnts |
| Credits | Useful Links |
| Rankings & Stats |
|---|
| Overview | Calendar |
| CQ Ranking | Subrankings |
| Head 2 Head | Downloads |
| Search |
|---|
| Riders | Races |
| Teams | Results |
 |
 |
|
|
Current CQ-value:
Rank:
0
CQ
-
|
|||||||||||||||||||||
|
RTS - Monton |
|||||||||||||||||||||||
ORTEGA RAMIREZ Mauricio
| Teams & Results | Photos | Stats |
|---|
| Year | Team | Class | Rank | Points | Results | Results | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |  | Ningxia Sports Lottery - Livall Cycling Team | CONT | 2418 | 5 | All | Points | |||||||||
| → Contract from 3/07 | ||||||||||||||||
| 2017 |  | RTS - Monton Racing Team | CONT | 271 | 248 | All | Points | |||||||||
| 2016 | | RTS - Monton Racing Team | CONT | 224 | 291 | All | Points | |||||||||
| → Contract from 1/07 | ||||||||||||||||
| 2015 |  | Orgullo Antioqueño | CONT | 1050 | 41 | All | Points | |||||||||
| 2014 | Elite-2 | 1469 | 18 | All | Points | |||||||||||
| 2013 | Elite-2 | 1430 | 20 | All | Points | |||||||||||
| 2012 | | EPM - UNE | CONT | - | 0 | All | Points | |||||||||
| 2011 | | EPM - UNE | CONT | - | 0 | All | Points | |||||||||
| 2010 | | UNE - EPM | CONT | - | 0 | All | Points | |||||||||
| 2009 | Elite-2 | 1782 | 12 | All | Points | |||||||||||
| 2008 | Elite-2 | 1363 | 25 | All | Points | |||||||||||
| 2007 | Elite-2 | 1842 | 13 | All | Points | |||||||||||
| 2006 | | Atom | CONT | - | 0 | All | Points | |||||||||
| 2003 | Elite-2 | 632 | 70 | All | Points | |||||||||||
| 2002 | Elite-2 | - | 0 | All | Points | |||||||||||
| All years | All | Points | ||||||||||||||
| CQ-value History | ||
|---|---|---|
|
|
||
|
Red = Year Value Blue = Current Value |
| Rider Comment | ||
|---|---|---|
Mauricio ORTEGA tested positive for Salbutamol in the Tour of Hainan on 23 October 2018. He was suspended by the UCI for 9 months, until 1 November 2019. |
3/11/2025 - Remarks or suggestions? Mail to info@cqranking.com
CQ Ranking - Copyright © 2025, Credits